Correction to Lancet Respir Med 2024; 12: 714–27

IF 32.8 1区医学 Q1 CRITICAL CARE MEDICINE

Lancet Respiratory Medicine Pub Date : 2025-06-23 DOI:10.1016/s2213-2600(25)00235-8

引用次数: 0

Abstract

Meslé MMI, Brown J, Mook P, et al. Estimated number of lives directly saved by COVID-19 vaccination programmes in the WHO European Region from December, 2020, to March, 2023: a retrospective surveillance study. Lancet Respir Med 2024; 12: 714–27—In this Article, changes have been made in the Summary (Findings section and first sentence in the Interpretation section), Research in context panel (second-to-last sentence of the Added value of this study section and last sentence of the Implications of all the available evidence section), Methods (second sentence of first paragraph and the fourth paragraph in the Data analysis section), Results (paragraphs five and seven), figure 2 heading, and Discussion (paragraph five) to clarify the definition of the boosters doses and the authors' interpretation of their differential role in saving lives. These corrections were made June 23, 2025.

查看原文本刊更多论文

柳叶刀呼吸医学2024修正；12: 714 - 27所示

李建军，李建军，李建军，等。2020年12月至2023年3月世卫组织欧洲区域COVID-19疫苗接种规划直接挽救的生命估计数：一项回顾性监测研究柳叶刀呼吸医学2024；12:714 - 27在本文中，总结部分（发现部分和解释部分的第一句）、上下文研究部分（本研究的附加值部分的倒数第二句和所有可用证据的含义部分的最后一句）、方法（数据分析部分的第一段第二句和第四段）、结果（第5段和第7段）、图2标题、以及讨论（第5段），以澄清增强剂剂量的定义以及作者对它们在拯救生命方面的不同作用的解释。这些更正是在2025年6月23日作出的。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Lancet Respiratory Medicine RESPIRATORY SYSTEM-RESPIRATORY SYSTEM

CiteScore

87.10

自引率

0.70%

发文量

572

期刊介绍： The Lancet Respiratory Medicine is a renowned journal specializing in respiratory medicine and critical care. Our publication features original research that aims to advocate for change or shed light on clinical practices in the field. Additionally, we provide informative reviews on various topics related to respiratory medicine and critical care, ensuring a comprehensive coverage of the subject. The journal covers a wide range of topics including but not limited to asthma, acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), tobacco control, intensive care medicine, lung cancer, cystic fibrosis, pneumonia, sarcoidosis, sepsis, mesothelioma, sleep medicine, thoracic and reconstructive surgery, tuberculosis, palliative medicine, influenza, pulmonary hypertension, pulmonary vascular disease, and respiratory infections. By encompassing such a broad spectrum of subjects, we strive to address the diverse needs and interests of our readership.